219 related articles for article (PubMed ID: 7923984)
21. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
Götz AK; Böger CA; Popal M; Banas B; Krämer BK
Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
[TBL] [Abstract][Full Text] [Related]
22. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
23. Dialysis membrane biocompatibility: effects on cellular elements.
Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
[No Abstract] [Full Text] [Related]
24. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
Locatelli F
N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
[No Abstract] [Full Text] [Related]
25. [Atherosclerosis and hemodialysis].
Kessler M
Nephrologie; 2000; 21(7):349-50. PubMed ID: 11200608
[No Abstract] [Full Text] [Related]
26. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
27. High flux dialysis membranes improve plasma lipoprotein profiles in patients with end-stage renal disease.
Goldberg IJ; Kaufman AM; Lavarias VA; Vanni-Reyes T; Levin NW
Nephrol Dial Transplant; 1996; 11 Suppl 2():104-7. PubMed ID: 8804007
[TBL] [Abstract][Full Text] [Related]
28. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
Friedman EA
N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
[No Abstract] [Full Text] [Related]
29. Biocompatible membranes and hemodynamic tolerance to hemodialysis.
Branger B; Deschodt G; Oules R; Balducchi JP; Granolleras C; Alsabadani B; Fourcade J; Shaldon S
Kidney Int Suppl; 1988 Mar; 24():S196-7. PubMed ID: 3163048
[No Abstract] [Full Text] [Related]
30. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
31. The hemodialysis membranes: a historical perspective, current state and future prospect.
Cheung AK; Leypoldt JK
Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
[TBL] [Abstract][Full Text] [Related]
32. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
Valeri A; Radhakrishnan J; Ryan R; Powell D
Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
[TBL] [Abstract][Full Text] [Related]
33. The practical application of ozone in dialysis.
Amato RL; Curtis J
Nephrol News Issues; 2002 Sep; 16(10):27-30. PubMed ID: 12271927
[No Abstract] [Full Text] [Related]
34. Back to basics. Selecting dialyzers appropriate for patients and facilities.
Highland K
Nephrol News Issues; 2002 Sep; 16(10):17-21. PubMed ID: 12271925
[No Abstract] [Full Text] [Related]
35. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis.
de Gómez Dumm NT; Giammona AM; Touceda LA; Raimondi C
Medicina (B Aires); 2001; 61(2):142-6. PubMed ID: 11374135
[TBL] [Abstract][Full Text] [Related]
36. Development of continuous implantable renal replacement: past and future.
Fissell WH; Fleischman AJ; Humes HD; Roy S
Transl Res; 2007 Dec; 150(6):327-36. PubMed ID: 18022594
[TBL] [Abstract][Full Text] [Related]
37. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
Mrowka C; Heintz B; Sieberth HG
Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
[TBL] [Abstract][Full Text] [Related]
38. [Influence of dialysis membranes on lipid parameters].
de Précigout V
Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611
[No Abstract] [Full Text] [Related]
39. Evolution of techniques for multiple use of dialyzers.
Deane N; Bemis JA
Proc Clin Dial Transplant Forum; 1980; 10():74-8. PubMed ID: 6810355
[No Abstract] [Full Text] [Related]
40. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
